Automated Titration for Home Oxygen Therapy
Effectiveness of Automated Titration Designed for Home Oxygen Therapy
1 other identifier
interventional
25
1 country
1
Brief Summary
Patients with chronic respiratory disease may be prescribed oxygen therapy. Currently, the dose of oxygen flow is fixed (FixedO2) depending on activity level i.e. rest, physical activity and sleep. Automated Titration of Oxygen (AutoO2) is a closed-loop system in which the oxygen flow to the patient is continuously machine adjusted to meet the patient's immediate needs on the basis of signals from pulse oximetry (SpO2). The purpose of this study is to examine if automated oxygen control based on pulse oximetry provided to participants is superior to prescribed fixed oxygen flow in keeping SpO2 within the intended target interval of 92 to 96% arterial oxygen saturation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2023
CompletedFirst Posted
Study publicly available on registry
December 1, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 4, 2025
November 1, 2025
2.7 years
November 2, 2023
November 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Daily time spent normoxic as defined by an arterial oxygen saturation measured by pulse oximetry (SpO2), between 92 to 96%, will be expressed a function of total time recorded SpO2.
SpO2 will be recorded throughout the day (24 hours). The primary outcome measure equals the daily time with 92%≥SpO2≤ 96% (numerator) divided by the total daily time of measured SpO2 (denominator).
24 hour
Study Arms (2)
AutoO2
EXPERIMENTALAutomated Titration of Oxygen (Auto-O2) using a closed-loop system in which the oxygen flow to the participant is continuously adjusted on the basis of pulse oximetry signals to maintain a target range of oxygen saturation to meet the patient's immediate needs.
FixedO2
ACTIVE COMPARATORFixed flow oxygen delivery administered using manual flow meters according to standard clinical procedures.
Interventions
Automated Titration of Oxygen (Auto-O2) using a closed-loop system in which the oxygen flow to the participant is continuously adjusted on the basis of pulse oximetry signals to maintain a target range of oxygen saturation to meet the participant's immediate needs.
Fixed flow oxygen delivery administered using manual flow meters according to standard clinical procedures.
Eligibility Criteria
You may qualify if:
- stable chronic respiratory disease
- current prescription for supplemental oxygen therapy
You may not qualify if:
- characteristics that compromise the validity of oximetry
- inability to communicate in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West Park Healthcare Centre
Toronto, Ontario, M6M 2J5, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Program in Respiratory Rehabilitation
Study Record Dates
First Submitted
November 2, 2023
First Posted
December 1, 2023
Study Start
December 1, 2023
Primary Completion (Estimated)
July 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share